Anixa Biosciences Inc — Director's Dealing 2017

Sep 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-09-06

Reporting Person: Titterton Lewis H jr (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-06	Employee Stock Option	$2.575	D	30000	Disposed	2022-09-19	Common Stock (30000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	30000	Acquired	2022-09-19	Common Stock (30000)	Direct
2017-09-06	Employee Stock Option	$2.575	D	40000	Disposed	2023-02-15	Common Stock (40000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	40000	Acquired	2023-02-15	Common Stock (40000)	Direct
2017-09-06	Employee Stock Option	$2.575	D	16000	Disposed	2022-12-31	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	16000	Acquired	2022-12-31	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$0.82	D	6000	Disposed	2027-07-17	Common Stock (6000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	6000	Acquired	2027-07-17	Common Stock (6000)	Direct
2017-09-06	Employee Stock Option	$2.575	D	2400	Disposed	2017-11-30	Common Stock (2400)	Direct
2017-09-06	Employee Stock Option	$0.67	A	2400	Acquired	2017-11-30	Common Stock (2400)	Direct
2017-09-06	Employee Stock Option	$2.575	D	120000	Disposed	2023-11-08	Common Stock (120000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	120000	Acquired	2023-11-08	Common Stock (120000)	Direct
2017-09-06	Employee Stock Option	$2.575	D	16000	Disposed	2023-12-31	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	16000	Acquired	2023-12-31	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$2.575	D	16000	Disposed	2025-01-02	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	16000	Acquired	2025-01-02	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$2.92	D	16000	Disposed	2026-01-14	Common Stock (16000)	Direct
2017-09-06	Employee Stock Option	$0.67	A	16000	Acquired	2026-01-14	Common Stock (16000)	Direct

Footnotes

F1: These transactions involved an amendment of outstanding stock options for the sole purpose of lowering the exercise price, resulting in the deemed cancellation of the "old" options and the grant of replacement options. All of the other terms of the options remain the same, including without limitation, the number of shares underlying the options, the vesting periods of the options, and the expiration dates of the options.

F2: The option was originally granted on September 19, 2012 and vested as follows: one third immediately and two thirds annually beginning on September 19, 2013.

F3: The option was originally granted on February 15, 2013 and vested as follows: one third immediately and two thirds annually beginning on February 15, 2014.

F4: The option was originally granted on March 28 2013 and vested in in four (4) equal installments on each March 31, 2013, June 30, 2013, September 30, 2013 and December 31, 2013.

F5: The option was originally granted on July 17, 2017 and vests and become exercisable in two equal installments on each September 30, 2017 and December 31, 2017.

F6: The option was originally granted on November 30, 2012 and vested immediately.

F7: The option was originally granted on November 8, 2013 and vested in 36 consecutive monthly installments beginning on December 31, 2013.

F8: The option was originally granted on January 2, 2014 and vested in four (4) equal installments on each of March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014.

F9: The option was originally granted on January 2, 2015 and vested in four (4) equal installments on each of March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015.

F10: The option was originally granted on February 18, 2016 and vested in four (4) equal installments on each of March 31, 2016, June 30, 2016, September 30, 2016 and December 31, 2016.